6-2 0 balanced

gene and chromosome 7; Polysomy: 3 1-4 4 b

6-2.0 balanced

gene and chromosome 7; Polysomy: 3.1-4.4 balanced gene and chromosome 7 Concordance 97%; k = 0.78; p < 0.0001; Sensitivity 67%; Specificity 100%; Positive predictive value 100%; Negative predictive value 97% Only 1 NSCLC was NA by CISH (gene-to-chromosome 7 ratio 1.2) and amplified by FISH (gene-to-chromosome ratio 2.5). The k coefficient for the inter-assay agreement was 0.78 EPZ5676 ic50 (95% CI: 45%-100% P < 0.0001). Therefore, sensitivity for CISH was 67%, specificity was 100%, PPV was 100% and NPV was 97%. Discussion The present study aimed to evaluate the effectiveness of CISH to detect EGFR GCN on FFPE sections from FNAC cell blocks obtained from NSCLC and CRC pulmonary metastases. Our findings demonstrated that: a) lung FNAC nodules provide useful material to detect the EGFR status by in situ hybridization, b) the CISH PRIMA-1MET datasheet technique

is sensitive and specific in determining EGFR GCN, c) CISH and FISH correlate between them, while there is no association between EGFR GCN and IHC overexpression. Previous studies already demonstrated that CISH is a useful technique for the detection of EGFR and HER2 gene amplification in breast [19] and lung cancer [18] FNAC both in conventional and in monolayered MDV3100 order smears obtained by liquid based cytology. Herein, we showed that the CISH analysis performed on cell blocks from lung FNAC is also a valuable method for establishing selleck chemical the EGFR gene content in pulmonary neoplastic nodules and, as reported by other authors [18, 20], there

is a close association with the results provided by FISH. To our knowledge, no previous studies have made a direct comparison between the CISH and FISH analyses in cytological specimens from lung tumors using cell block preparation. This methodological approach could be of clinical interest in the diagnosis of lung nodules since it may reduce the undetermined diagnoses distinguishing tumor histotype known to better respond to anti-EGFR targeted therapies [21, 22]. Primary lung carcinomas as well as mCRC are often unresectable [23] leading to the use of FNAC procedures or bronchoscope tissue biopsy to obtain diagnostic cellular material. However, conventional cytology has not been widely used for biological analysis, primarily due to heterogeneity within samples or to the limited percentage of tumor cells usually present in the cytological smears. The method we described may be particularly useful in patients who are not candidates for surgery and may be used also on other cytological specimens as pleural effusions or bronchoalveolar lavages. In our series of 20 primary NSCLC and 13 mCRC, CISH evidenced EGFR gene amplification only in NSCLC (2/20, 10%) and an elevated incidence of high polysomy (40% NSCLC and 53% mCRC).

Comments are closed.